Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Medis Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1457)
ARTG (51)
Cancellation or suspension (26)
Listed medicine compliance report (5)
Prescription medicine registration (2)

Date

2025 (58)
2024 (1215)
2023 (3)
2022 (29)
2021 (106)
2020 (31)
2019 (6)
2018 (3)
2017 (44)
2016 (5)
2015 (17)
2014 (7)
2013 (2)
2012 (7)
2011 (6)
2010 (1)
2009 (1)

Search

Sponsor content

1541 result(s) found, displaying 1501 to 1510

IRBESARTAN HCT MEDIS 150/12.5 irbesartan/hydrochlorothiazide 150 mg/12.5 mg tablet blister Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
GEMCITABINE ACTAVIS 1000 gemcitabine 1000 mg (as hydrochloride) powder for injection vial Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
PANTOPRAZOLE ACTAVIS pantoprazole 40 mg (as sodium sesquihydrate) enteric-coated tablet bottle Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
PRAVAT 20 pravastatin sodium 20 mg tablet blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
STADA PANTOPRAZOLE pantoprazole (as sodium sesquihydrate) 40 mg enteric-coated tablet blister Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
PRAVAT 40 pravastatin sodium 40 mg tablet blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
VENLAFAXINE ACTAVIS XR venlafaxine (as hydrochloride) 37.5 mg modified release capsule blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
VENLAFAXINE ACTAVIS XR venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
VENLAFAXINE ACTAVIS XR venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
GLIMEPIRIDE WATSON 1 glimepiride 1 mg tablet blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd

Pages

First page
Previous page
…
Page 147
Page 148
Page 149
Page 150
Current page 151
Page 152
Page 153
Page 154
Page 155
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.